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This research was designed to investigate patterns of research misconduct across institutions in 
the United States in the past decade. Certain factors such as type of institution, size of the institution, 
funding of institution, number of publications, year of retraction, research administration structure, and 
occurrence rates were explored. The retraction database, National Institutes of Health (NIH), Office of 
Research Integrity (ORI), and individual institution websites provided access to information and or data 
on 336 retracted articles during the past decade. The publically available data was analyzed using 
standard statistical methods. The analysis of data supports that on average it takes 5.8 years for articles 
involved in research misconduct to be retracted. 2015 had the highest number of retracted articles (74) 
while 2011 had the lowest (6). 85% of research misconduct related retracted articles are from 
universities. The NIH had the most repeated research misconduct cases, having multiple retracted 
articles across various years (2009, 2014, 2015, 2016, 2017, 2018). Out of 81 institutions, 38 (47%) had 
repeat offenses for at least 1+ year of research misconduct cases. The study provided evidence that there 
is a relationship between the amount of funding and the number of retracted articles. The relationship is 
negative meaning that the probability of having an article retracted is greater for smaller funded 
programs than higher funded programs. Throughout the decade there has been an increase trend of 
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What is research misconduct? 
The National Institutes of Health (NIH) and the Office of Research Integrity (ORI) defines 
research misconduct as: “fabrication, falsification, or plagiarism in proposing, performing, or reviewing 
research, or in reporting research results. 
(a) Fabrication is making up data or results and recording or reporting them. 
(b) Falsification is manipulating research materials, equipment, or processes, or changing or 
omitting data or results such that the research is not accurately represented in the research 
record. 
(c) Plagiarism is the appropriation of another person’s ideas, processes, results, or words without 
giving appropriate credit. 
(d) Research misconduct does not include honest error or differences of opinion. 
Misconduct must be an intentional or reckless departure from accepted practices of the relevant research 
community” (NIH, 2019).   
Types of research misconduct:  
There are various classifications of research misconduct that can occur throughout the research 
process such as misappropriation of ideas, plagiarism, impropriety of authorship, failure to comply with 
legislative and regulatory requirements, violation of generally accepted research practices, and 
falsification of data. This study focuses on falsification and fabrication of data during publications of 
research.  




Breach of Policy by Author A violation of the journal, publisher or institutional accepted practices by the 
author. 
Breach of Policy by Third 
Party 
A violation of the journal, publisher or institutional accepted practices by a 
person or company/institution not the authors. 
Civil Proceedings Non-criminal litigation arising from the publication of the original article or 
the related notice(s). 




Allegations made strictly about the author’s affiliation(s) without respect to 
the original article. 
Complaints about Third 
Party 
Allegations made strictly about those not the author or the author’s 
affiliation(s) without respect to the original article. 
Concerns/Issues About 
Authorship 
Any question, controversy or dispute over the rightful claim to authorship, 
excluding forged authorship. 
Concerns/Issues About 
Data 
Any question, controversy or dispute over the validity of the data. 
Concerns/Issues About 
Image 
Any question, controversy or dispute over the validity of the image. 
Concerns/Issues about 
Referencing/Attributions 
Any question, controversy or dispute over whether ideas, analyses, text or data 
are properly credited to the originator. 
Concerns/Issues About 
Results 
Any question, controversy or dispute over the validity of the results. 
Concerns/Issues about 
Third Party Involvement 
Any question, controversy or dispute over the rightful claim to authorship, 
excluding forged authorship. 
Conflict of Interest Authors having affiliations with companies, associations, or institutions that 
may serve to influence their belief about their findings. 
Criminal Proceedings Court actions that may result in incarceration or fines arising from the 
publication of the original article or the related notice(s). 
Duplication of Article Also known as “self-plagiarism”.  Used when an entire published item, or 
undefined sections of it, written by one or all authors of the original article, are 
repeated in the original article without appropriate citation.   
Duplication of Data Also known as “self-plagiarism”.  Used when all or part of the data from an 
item written by one or all authors of the original article, are repeated in the 




Duplication of Image Also known as “self-plagiarism”.  Used when an image from an item written 
by one or all authors of the original article is repeated in the original article 
without appropriate citation.   
Duplication of Text Also known as “self-plagiarism”.  Used when sections of text from an item 
written by one or all authors of the original article, are repeated in the original 
article without appropriate citation.   
Ethical Violations by 
Author 
When an author performs an action contrary to accepted standards of 
behavior.  Generally used only when stated as such in the notice and no other 
specific reason (e.g., duplication of image) is given.   
Ethical Violations by Third 
Party 
When any person not an author performs an action contrary to accepted 
standards of behavior.  Generally used only when stated as such in the notice 
and no other specific reason (e.g., duplication of image) is given.   
Euphemisms for 
Duplication 
The notice does not clearly state that the authors reused ideas, text, or images 
from one of their previously published items without suitable citation. 
Euphemisms for 
Misconduct 
The notice does not clearly state that the reason for the notice is due to 
fabrication, falsification, or plagiarism by one or all the authors, despite an 
institutional report stating such. 
Euphemisms for 
Plagiarism 
The notice does not clearly state that the authors reused ideas, text, or images, 
without suitable citation, from items published by those not the authors. 
Fake Peer Review The peer review was intentionally not performed in accordance with the 
journal’s guidelines or ethical standards. 
Falsification/Fabrication of 
Data 
Intentional changes to data so that it is not representative of the actual finding. 
Falsification/Fabrication of 
Image 




Intentional changes to results so that it is not representative of the actual 
finding. 
Forged Authorship The fraudulent use of an author’s name in submitting a manuscript for 
publication. 
Hoax Paper Paper intentionally drafted with fraudulent data or information with the 
specific intent of testing a journal’s or publisher’s manuscript acceptance 
policies. 
Informed/Patient Consent – 
None/Withdrawn 
When the full risks and benefits from being in an experiment are not provided 







An evaluation of allegations by the affiliations of one or all of the authors. 
Investigation by 
Journal/Publisher 
An evaluation of allegations by the journal or publisher. 
Investigation by ORI An evaluation of allegations by the United State Office of Research Integrity. 
Investigation by Third 
Party 
An evaluation of allegations by a person, company or institution not the 
Authors, Journal, Publisher or ORI. 
Lack of Approval from 
Author 
Failure to obtain agreement from original author(s). 
Lack of Approval from 
Company/Institution 
Failure to obtain agreement from original author(s). 
Lack of Approval from 
Third Party 
Failure to obtain agreement from original author(s). 
Lack Of Balance/Bias 
Issues 
Failure to maintain objectivity in the presentation or analysis of information. 
Lack of IRB/IACUC 
Approval 
Failure to obtain consent from the institutional ethical review board 
overseeing human or animal experimentation. 
Legal Reasons/Legal 
Threats 
Actions taken to avoid or foster litigation. 
Manipulation of Images The changing of the presentation of an image by reversal, rotation or similar 
action. 
Manipulation of Results The changing of the presentation of results which may lead to conclusions not 
otherwise warranted. 
Misconduct – Official 
Investigation/Finding 
Finding of misconduct after investigation by incorporated company, institution 
of governmental agency. 
Misconduct by Author Statement by journal, publisher, company, institution, governmental agency, 
or author that author committed misconduct. 
Misconduct by 
Company/Institution 
Statement by journal, publisher, company, institution, or governmental agency 
that company/institution committed misconduct. 
Misconduct by Third Party Statement by journal, publisher, company, institution, or governmental agency 
that a third party committed misconduct. 
Objections by Author(s) A complaint by any of the original authors or refusal to agree on actions taken 






A complaint by any of the original authors’ affiliation(s) or refusal by same to 
agree on actions taken by the journal or publisher. 
Objections by Third Party A complaint by any person, company or institution not of the original authors, 
or refusal by same to agree on actions taken by the journal or publisher. 
Plagiarism of Article Used when an entire published item, or undefined sections of it, and not 
written by one or all authors of the original article, are repeated in the original 
article without appropriate citation.   
Plagiarism of Data Used when the all or part of the data from an item not written by one or all 
authors of the original article, are repeated in the original article without 
appropriate citation.   
Plagiarism of Image Used when an image from an item not written by one or all authors of the 
original article is repeated in the original article without appropriate citation.   
Plagiarism of Text Used when sections of text from an item not written by one or all authors of 
the original article, are repeated in the original article without appropriate 
citation.   
Publishing Ban A Journal or Publisher states that no manuscripts will be acceptance from one 
or all the authors of the original article.  It can be for a limited time, or 
indefinitely. 
Results Not Reproducible Experiments conducted, using the same materials and methods, that fail to 
replicate the finding of the original article. 
Retract and Replace The permanent change of an item to a non-citable status, with a subsequent 
republication by the same journal after substantial changes to the item. 
Sabotage of Materials An intentional action to surreptitiously change or contaminate experimental 
ingredients in order to artificially change the experimental outcome. 
Sabotage of Methods An intentional action to surreptitiously change or contaminate experimental 
instruments or tools in order to artificially change the experimental outcome. 
Salami Slicing The publication of several articles by using the same (small) dataset, but by 
breaking it into sections, with the intent of exploiting a limited data set for the 
production of several published works.  This does not apply to large multi-
group studies. 
Unreliable Data The accuracy or validity of the data is questionable. 
Unreliable Image The accuracy or validity of the image is questionable. 
Unreliable Results The accuracy or validity of the results is questionable. 
Table 1- Summary of reasons for article retraction 




History of research misconduct: 
The history of research has had its positive and negative effects; while much advancement has 
been made, the way studies have been conducted has not always been ethically correct. For instance, 
there are cases like, Dong-Pyou Han, a former biomedical scientist at Iowa State University, who 
admitted to falsifying the results of several vaccine experiments, Eric Poehlman, an expert on aging and 
obesity at the University of Vermont, who became the first American scientist sentenced to jail for 
research misconduct not involving fatalities, and Scott Reuben, a prominent Massachusetts 
anesthesiologist and researcher, who was found to have faked data in at least 21 studies (Nutt, 2016). 
Unfortunately, there have been other cases that are part of research’s history of disreputable studies. 
Such trials caused a negative public stigma around the execution of research that has directly impacted 
scientific innovation to the present day. Over time there has been a great shift to properly govern 
research, however, skepticism still exists.  
Beginning in the 1970s and 1980s, research misconduct was brought to the public’s attention 
and Congressional scrutiny, which led to public statements, policies, and formal federal regulations by 
Government agency officials. The Office of Research Integrity (ORI) in the Department of Health and 
Human Services was a major component of this process. (Price, 2013)  
What laws are in place? 
 In 1985, Congress took action by passing the Health Research Extension Act. It was added to 
Section 493 of the Public Health Service (PHS) Act, which required the Secretary of Health and Human 
Services to issue a regulation requiring applicant or awardee institutions to establish, “an administrative 
process to review reports of scientific fraud,” and, “report to the Secretary any investigation of alleged 
scientific fraud, which appears substantial.” The Section also required the NIH Director to start a 




in the NIH Guide for Grants and Contracts. The Final Rule, “Responsibilities of Awardee and Applicant 
Institutions for Dealing With and Reporting Possible Misconduct in Science,” was published in the 
Federal Register on August 8, 1989 and codified as 42 CFR Part 50, Subpart A. In June 1993, the 
process of removing responsibility for handling allegations of research misconduct from the funding 
agencies was completed when President Clinton signed the NIH Revitalization Act of 1993. This Act 
established the ORI as an independent entity within Health and Human Services (HHS) and replaced the 
term, “scientific misconduct” with, “research misconduct” (ORI, n.d.). The HHS adopted the proposed 
government wide definition of research misconduct developed by the National Science and Technology 
Council that was published in the Federal Register on October 13, 1999. The Federal Research 
Misconduct Policy containing the final definition was published in the Federal Register on December 6, 
2000 (U.S. Department of Health, n.d.). Currently, research misconduct is not considered a criminal 
offense; however, there have been numerous discussions on its criminalization in bioethical literature.  
Underlying factors  
 There are several possible explanations for why research misconduct may occur. It is 
challenging to identify what the underlying causes of research misconduct are. Is it due to lack of 
knowledge, training, and resources? Or is it due to culture, pressure, and lack of oversight or 
infrastructure with our institutions or governance?  Is the institution more at fault or the individual 
researchers? 
 There is an enormous pressure to constantly publish as a researcher that can cause some to 
attempt to cut corners on how they conduct their research. There could be cases where the Principle 
Investigator does not oversee his or her research staff, or an institution is not providing the necessary 
resources to regulate the research being done, or that individuals involved do not conduct research 




Several complications come with identifying research misconduct. It is difficult to quantify the 
number of research misconduct cases that are reported and documented versus the cases that have never 
been reported. Having such cases in the public eye is detrimental to the entities involved, provoking 
them to often handle the cases in an undisclosed manner. Based on surveys conducted on researchers, 
there are much higher estimates of research misconduct than reported in the literature (National 
Academies of Science, 2017).  
Programs  
Each institution has established policies and types of programs for research misconduct. 
Additionally, these entities have specific means of auditing and evoking consequences. Most 
universities have similar policies while companies might have more diversity that is dependent on 
specific company policies. Researchers are required and expected to follow federal, state and 
institutional laws. University’s Research Integrity Officers (RIO) is responsible for implementing 
policies on research misconduct. Institutions have research misconduct teachings, learning tools, and 
trainings. Furthermore, it is typical to have a specific committee, monitoring or office for regulation of 
misconduct.   
The Association of American Universities (AAU), the Association of American Medical 
Colleges (AAMC), and other national organizations as well as government agencies have established a 
Committee on the Integrity of Research. They recognized a need for universities to collaborate with 
professional societies and related organizations in the examination of the sources of such problems and 
remedies available to them (National Research Council, 1989). 
There are specific misconduct procedures depending on the case. Initially there is an 
investigation, and depending on the findings, papers can be retracted, an agreement can be settled, 




case-by-case basis. A more serious breach of research misconduct usually results in harsher disciplinary 
action. Institutions can find out about cases through various means such as the researchers involved, the 
subjects, researchers at a different institution, federal agencies, reviewers, or journal articles.  



















Chapter 2 Review of Literature 
Literature review:  
There have been specific studies that have investigated research misconduct throughout the 
years. One in particular examined the interval between publication and retraction for 2,047 retracted 
articles indexed in PubMed. Time-to-retraction (from publication of article to publication of retraction) 
averaged 32.91 months (2.74 years). Among 714 retracted articles published in or before 2002, 
retraction required 49.82 months; among 1,333 retracted articles published after 2002, retraction 
required 23.82 months (p<0.0001). This suggests that journals are retracting papers more quickly than in 
the past, although recent articles requiring retraction may not have been recognized yet. (Steen, 2013)  
Another article explored the text of 291 articles originating from the United States that were 
published between 1992 and 2012 and were retracted for research misconduct. (Fang et al., 2012) Of the 
articles included in this analysis, 95.9% were retracted due to data falsification or fabrication, with the 
remainder involving other forms of serious misconduct such as publication without institutional review 
board (IRB) approval. (Stern, 2014)  
An alternative study included data from 621 retracted studies in their analysis. This study 
reported that the number and rate of retractions have increased since 2010. The most common reasons 
for retraction are errors (148), plagiarism (142), duplicate publication (101), fraud/suspected fraud (98), 
and invalid peer review (93). The number of retracted articles from Open Access Journals (OAJs) has 
been steadily increasing. Misconduct was the primary reason for retraction. (Wang, 2019) 
Retractions are rare compared to the number of publications; among all articles in the biomedical 
database, PubMed, no higher than 0.02% (Amos, 2014; Wager and Williams, 2011) or considerably 




of retractions is cumbersome since existing studies employ different search strategies and sample 
limitations. Time lags contribute to these differences between studies as retractions take up to 35 months 
to be updated, (Decullier et al., 2014) so that the complete number of retractions for a given year might 
not be accessible until three years later. (Sociol, 2017)  
One study found that between the years 2000-2015, 134 retraction notices were published. 
Although they account for 0.07% of all articles published (190,514 excluding supplements, corrections, 
retractions and commissioned content), the rate of retraction is rising. The largest proportion of notices 
was issued by the authors (47 articles, 35%). The majority of retractions were due to some form of 
misconduct (102 articles, 76%), that is, compromised peer review (44 articles, 33%), plagiarism (22 
articles, 16%) and data falsification/fabrication (10 articles, 7%). (Moylen, 2016)  
Many studies have investigated the number of retracted articles, the time it takes to retract 
articles, how much cost is involved in research misconduct, and the consequences that occur after such 
cases. However, there has not been any focus on whether higher versus lower funded institutions are 
more or less likely to have increased retracted articles. What types of research entities have high 
retracted articles due to falsification of data? What percentages of retracted articles come from the same 












Chapter 3 Problem Statement 
Research Objectives 
This thesis will explore research misconduct cases around the United States by searching what 
data is publicly available in the past decade (2009-2019). The types of organizations that have had 
misconduct cases (private versus public, hospitals, universities, companies), the likelihood of 
misconduct incidents repeating, the funding level that these organizations receive, and the retraction rate 
of articles will be explored. Additionally, the institution’s infrastructure will be reviewed to see how the 




     Chapter 4 Methodology 
Publicly available information from various sources was used to organize data that will be 
informative on research misconduct in the past decade. The ORI (research misconduct cases), NIH 
(funding), Retracted Publications Database, Institution’s sites (programs, trainings, policies), and 
Scopus (database of articles) were all sources weighed for analysis.  
Data was pulled from the Retracted Publications Database including the retraction reasons, the 
institution involved, first author, additional authors, year of original paper publication, and retraction 
year. Specifically, the falsification of data in the United States between the years of 2009 – 2019 was the 
search criteria used for the database. NIH databases provided the amount of NIH funding during the 
article publication year, and Scopus supplied the number of total articles for each given institution 
during that same year. Statistical analysis was conducted on the types of institutions with retracted 
articles, the average time it takes for articles to be retracted, and funding versus articles retracted.  
Anticipated results 
It was anticipated that higher funding institutions would have an increased chance of publically 
known research misconduct cases. Additionally, it might be more likely that lower funded institutions 
will have more retracted articles. Public entities are more likely to have research misconduct cases than 




Chapter 5 Data Analysis 
The ORI only provided information on 26 institutions for research misconduct between the years of 
2009-2019, while this study determined there were 70 total intuitions containing research misconduct in 
this time frame.         
Total ORI reported research misconduct case findings that are available publicly: 
PI and institution Year 
William W. Cruikshank, Ph.D., Boston University School of Medicine 2019 
Edward J. Fox, Ph.D., University of Washington 2019 
Brandi M. Baughman, Ph.D., University of North Carolina at Chapel Hill 2018 
Maria Cristina Miron Elqutub, University of Texas MD Anderson Cancer Center 2018 
Rajendra Kadam, University of Colorado, Denver 2018 
Christian Kreipke, Ph.D., Wayne State University 2018 
Krishna Murthy, Ph.D., University of Alabama at Birmingham 2018 
Bhagavathi Narayanan, Ph.D., New York University 2018 
Uthra Rajamani, Ph.D., Cedars-Sinai Medical Center 2018 
Venkata Sudheer Kumar Ramadugu, Ph.D., University of Michigan 2018 
Srikanth Santhanam, Ph.D., Washington University in St. Louis 2018 
Shiladitya Sen, The Ohio State University 2018 
Colleen T. Skau, Ph.D., National Institutes of Health 2018 
Rakesh Srivastava, Ph.D., University of Kansas Medical Center 2018 
Li Wang, Ph.D., University of Connecticut 2018 
Brandi M. Baughman, Ph.D., National Institutes of Health (NIH) 2017 
Nasser Chegini, Ph.D., University of Florida 2017 
Mahandranauth Chetram, Ph.D., Georgetown University and Emory School of Medicine 2017 
Azza El-Remessy, Ph.D., University of Georgia, College of Pharmacy 2017 




Alec Mirchandani, Florida Atlantic University 2017 
Frank Sauer, Ph.D., University of California, Riverside 2017 
Andrew R. Cullinane, Ph.D., National Institutes of Health 2016 
Zhiyu Li Ph.D., Mount Sinai School of Medicine 2016 
Ricky Malhotra, Ph.D., University of Michigan and University of Chicago 2016 
John G. Pastorino, Ph.D., Rowan University School of Osteopathic Medicine 2016 
Anil Potti, M.D., Duke University School of Medicine 2015 
Eric J. Smart, Ph.D., University of Kentucky 2012 
Mona Thiruchelvam, Ph.D., University of Medicine and Dentistry of New Jersey 2012 
Table 2  
 
Results 
                 The source of retracted articles between the years of 2009-2019: 










Additional reasons for retracted articles other than falsification of data: 
 
Figure 2 
Total articles retracted by year: 
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F- Test Total of retracted articles and NIH 
funding the year of the article publication by 
institutions: 
   
 NIH Funding 
Retracted    
Articles 
Mean  1.81E+08  4.191176 
 
Variance  5.78E+16  19.97783 
 
Observatio
ns  68  68 
 
df  67  67 
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Chapter 6 Discussion of Data Results 
The Office of Research Integrity only provided information on a select few research misconduct 
cases. The following statement is provided by ORI, “cases in which administrative actions were 
imposed due to findings of research misconduct are provided. The list only includes those who currently 
have an imposed administrative action against them. It does not include the names of individuals whose 
administrative actions periods have expired.” (ORI, n.d.) The ORI should consider providing case 
information on all research misconduct without limitations in order to provide this information to the 
public and scientific community.      
Most retracted articles due to fabrication of data were investigated by the institution / company 
(77%). While 33% involved the ORI, 9% the journal / publisher, and 6% a third party investigator. The 
number of retracted articles compared to the total number of published articles from each institution is a 
very small percentage (estimated .11%). 2015 had the greatest number of retracted articles, 74, 
compared to 2011 with 6. The data indicates that it takes an average of 5.8 years for articles to be 
retracted. 2018 had the highest retraction period of 8.6 years while 2010 was the lowest with an average 
of 4.1 years.  
The NIH and universities had a higher likelihood of repeat offenses compared to the other 
entities. The NIH had the most repeat research misconduct cases across the years (2009, 2014, 2015, 
2016, 2017, and 2018).  Harvard University had 5 years of cases while University of California, Baylor 
College, University of Texas, University of Florida, and Bentley College each had 4 years. The range of 
funding of these institutions is varied. Out of 81 institutions, 38 (47%) had repeat offenses for at least 1+ 




Furthermore, the study provided evidence that there is a relationship between the amount of 
funding and the number of retracted articles. The relationship is negative meaning that the probability of 
having an article retracted is greater for smaller funded programs compared to higher funded programs.   
There are some signs that may point to an increased possibility of research misconduct. Are 
patterns due to chance or due to drawn awareness after an initial research misconduct case at a particular 
institution?  
Similar to other datasets, there are limitations with this data. For instance, there are relatively 
few published studies, which are not freely comparable because of varying characterizations of research 
misconduct and the methods used for data collection. (Thiese, 2017) Total funding for all institutions is 
not readily available through public records. Institutions that do not receive NIH funding were not 
included. Additionally, research misconduct cases involving falsification / fabrication of data that never 
resulted in published and or retracted articles were not included. Data is not available on these cases.  
Universities are more at risk for falsification of data; this difference could be due to a variety of 
unique factors compared to those that private entities encounter. It would be substantial to explore the 
infrastructure difference between universities and other entities in regards to number of retracted articles 
due to research misconduct issues. Are the research misconduct programs different between these 
entities? Is there more regulation or more pressure? Or do these cases tend to be more distinguishable in 






Chapter 7 Conclusion 
Over the past decade misconduct in research has attracted increasing attention from the press, 
the public, government, and the research community. This attention was initially drawn by a few highly 
publicized instances of data fabrication, plagiarism, and misrepresentation.  
Federal amendments on the preservation of research data are expected to be enforced in every 
research establishment. Various agencies sole purpose is the conservation of research. And individual 
institutions have evident policies in place to protect their research. However research misconduct cases 
still continue to occur. There is a range of possible reasons for research misconduct: institutional failures 
of oversight, career and funding pressures, conflicts of interest, inadequate training, mentoring 
standards, and just social deviance patterns. It is essential to understand the balance between conflict of 
interest, code of conduct, and proper misconduct knowledge in order to ethically execute research.  
Additional resources should be utilized to lessen the retraction time of misconduct articles. 
Taking an average of 5.8 years can cause irreversible damage. Besides, in that time many cases can be 
overlooked or not have sufficient information during investigation. The NIH and universities have 
higher cases of repeated years of retracted articles; this could be attributable to an overall higher 
production on publications as well as an increased pressure and competition to publish. Once an 
institution is exposed for misconduct the disclosure may heighten oversight causing supplemental 
retractions. It was originally predicted that higher funded organizations would have an extended 
probability of retracted articles due to elevated total publishing. However, the data displayed it was in 
fact lower funded institutions with higher probability of retracted articles. This trend may be due to 
fewer resources and oversight.  
The responsibility of research misconduct does usually fall on the institution. Even though the 




misconduct for safety and validity since research has suggested an increased tendency in retracted 
articles. Meticulous regulations on all accounts will ensure that neither code of ethics nor the validity of 
research is put in jeopardy. Organizations should form committees ensuring that data is being closely 
supervised. It is fundamental that all laws, regulations, and policies be addressed from the beginning and 
continue to be taught and enforced thoroughly. Research members should be well aware of all 
regulations and be held accountable for any major risks they put others in. Research administrators, 
institutions, universities, and companies need to cultivate together in order to regulate and sustain how 
research is completed across the nation. Representatives from various disciplines should agree upon 
which guidelines they should follow for quality record keeping. It must be clear what is expected and 
for it to be overseen by a committee regularly. Each project should have proper instructions on how all 
team members should be recording the data. It is vital to have members managing the oversight of the 
collection and recording of all data across different departments and entities. Administrators should 
establish that all associated researchers be trained in a united fashion and incorporate a well-defined 
individual to come to for any help due to confusion, questions, or concerns. Shared source 
documentation and databases need to be organized and implemented throughout. Having consistent 
supervision and monitoring will allow for fewer instances of research misconduct. Research 
administrators should hold frequent meetings to confirm everyone is on the same page and preforming 
all facets of the research correctly. Communication is key throughout such obscure projects; all 
employees should be comfortable to come to research administrators for all issues.   
False data could be published without being reviewed causing individuals to be convinced by the 
findings reported, provoking possible injuries or even deaths. Research Integrity Officers are entrusted 
with the vigorous task to handle their institutions allegations of scientific misconduct. RIO’s 
responsibilities include: interviewing respondents and complainants, requisitioning data, analyzing 




within research institutions and with federal oversight agencies. Members should not give in to outside 
pressures and should report any misconduct that is noticed. Monitoring should be constant across all 
funding entities. It is essential to produce the most reliable data and ensure all regulations are met for 
the sake of others and promotion of discoveries as a whole. The legitimacy of research needs to be of 
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